Hi Aldo, What's New? Advances in Aldosterone in Health and Disease

16 Apr 2024 9 a.m. 10:30 a.m.
Hall E
CarlosSchreck Chairperson Hospital Italiano de Buenos Aires- NephrologyArgentina
KellyHaughton Chairperson SLANH, PanamaPanama

Session Description:
This session is designed to provide participants with a review of aldosterone physiology and pathophysiology, an understanding of how to block aldosterone deleterious effects and an introduction to latest therapies in this area.
Learning Objectives:
Identify key elements of aldosterone action in health and disease. Review information on the beneficial effects of aldosterone receptor blockage. Examine critically new aspects of aldosterone synthese blockade.

Time Session
9 a.m.
9:18 a.m.
Why Are Fewer Than I% Of Hypertensive Patients Ever Screened For Primary Aldosteronism?
John Funder Speaker John.Funder@hudson.org.auThe Hudson Institute of Medical Research Clayton 3168 Victoria Australia; Monash University, Clayton 3600 Victoria AustraliaAustralia
9:18 a.m.
9:36 a.m.
Aldosterone and Disease
JordanaCohen Speaker jco@pennmedicine.upenn.eduUniversity of PennsylvaniaUnited States
9:36 a.m.
9:54 a.m.
New Trials Using Aldosterone Synthese Blockade
MichelAzizi Speaker michel.azizi@aphp.frUniversité Paris Cité, Hypertension department, HôFrance
9:54 a.m.
10:15 a.m.
Targeting MR for Heart and Kidney Protection
HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands
10:15 a.m.
10:30 a.m.
Q and A